Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Gloria Gil Royo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Malaria Journal|April 16, 2015
Screening for an ivermectin slow-release formulation suitable for malaria vector controlCarlos Chaccour, Ángel Barrio, Ana Gloria Gil Royo, et al.
Experimental & Molecular Medicine|June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsSergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Human Gene Therapy|September 28, 2013
Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyriaAstrid Pañeda, Esperanza Lopez-Franco, Christine Kaeppel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Malaria Journal|April 16, 2015
Screening for an ivermectin slow-release formulation suitable for malaria vector controlCarlos Chaccour, Ángel Barrio, Ana Gloria Gil Royo, et al.
Experimental & Molecular Medicine|June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsSergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Human Gene Therapy|September 28, 2013
Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyriaAstrid Pañeda, Esperanza Lopez-Franco, Christine Kaeppel, et al.
Pageof 1